Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
Jonas
S
S
Department of General, Visceral and Transplantation Surgery, Charité-Virchow Klinikum, Humboldt University Berlin, Berlin, Germany.
Guckelberger
O
O
Tullius
S G
SG
Steinmüller
T
T
Müller
A R
AR
Grauhan
O
O
Langrehr
J M
JM
Bechstein
W O
WO
Neuhaus
P
P
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone